Skip to main content

Table 2 Lipid testing in the past 5 years by sex, age & cardiovascular disease (CVD) risk

From: Relationship between cardiovascular risk and lipid testing in one health care system: a retrospective cohort study

Row(%)

Low CVD risk (<10 %)

Moderate CVD risk (10-20 %)

High CVD risk (>20 %)

Cannot determine CVD risk

Lipid tests

Lipid tests

Lipid tests

a) Men

Age

0

1

2

3+

Total

0

1

2

3+

Total

0

1

2

3+

Total

Total

25-34

62.4

26.9

7.4

3.3

1654

50.0

25.0

12.5

12.5

8

0.0

100.0

0.0

0.0

1

643

35-44

43.1

38.1

11.6

7.1

3478

36.9

34.9

16.2

12.1

464

33.3

19.4

16.7

30.6

36

1312

45-54

29.7

42.6

17.5

10.2

2332

27.8

37.1

20.8

14.3

2631

28.3

32.5

19.1

20.2

754

1416

55-64

25.0

40.3

23.5

11.2

196

21.8

37.2

23.3

17.6

2909

21.4

33.7

23.0

21.9

2478

1117

65-79

0.0

0.0

100.0

0.0

1

14.0

29.1

28.4

28.4

278

19.1

28.1

24.4

28.4

2476

356

Total

42.7

37.1

12.8

7.4

7661

25.1

36.7

21.9

16.3

6290

21.4

31.1

23.1

24.5

5745

4844

b) Women

Age

0

1

2

3+

Total

0

1

2

3+

Total

0

1

2

3+

Total

Total

25-34

70.1

21.9

4.9

3.3

3259

    

0

    

0

438

35-44

47.0

35.2

11.6

6.3

6436

31.2

16.9

16.9

35.1

77

0.0

80.0

0.0

20.0

5

724

45-54

29.2

41.3

19.3

10.3

7993

29.0

34.4

20.1

16.5

780

18.1

22.3

22.3

37.2

94

1079

55-64

22.4

38.7

23.0

15.8

5485

21.2

33.9

26.3

18.6

2180

21.8

26.6

22.6

29.1

399

999

65-79

20.1

35.5

25.6

18.7

1019

21.7

32.4

24.6

21.3

2341

23.1

32.0

19.8

25.2

1300

456

Total

37.5

36.2

16.4

9.9

24192

22.7

33.1

24.5

19.7

5378

22.5

20.4

20.5

26.6

1798

3696

  1. Yellow shading indicates more testing than recommended by the United States Preventive Services Task Force (USPSTF) for persons with low CVD risk. Green shading indicates less testing than recommended for persons at moderate- and high-risk and who are not already on statins. Cross-hatch lines signify risk categories with no study subjects